Prostate cancer is among the most common forms of cancer in men, but it is also one of the most treatable—especially when detected early. One of the particular challenges of this disease is that it often develops silently, without noticeable symptoms for a long time. As a result, many men tend to underestimate the issue or only discover it when it has already reached an advanced stage.

Diagnosis is primarily made through a PSA (Prostate-Specific Antigen) blood test, in combination with a specialist urological consultation.

Do All Prostate Tumors Require Surgery?
We explored this topic with Professor Simone Albisinni, a specialist urologist with expertise in robotic surgery, with a focus on prostate cancer and functional urological disorders in both men and women.

So, do all prostate cancers need to be treated surgically, or are there alternative options?

In fact, not all prostate cancers require immediate treatment. A significant proportion of cases are slow-growing and unlikely to progress to metastatic disease. These are classified as Grade 1 tumors, or what was previously referred to as Gleason score 6 (3+3)—a low-aggressiveness form.

The Gleason score is a crucial parameter in urologic oncology used to grade the aggressiveness of prostate cancer.
Patients with low-grade disease are often ideal candidates for active surveillance, a management strategy involving regular monitoring through MRI scans, repeat biopsies, and clinical evaluations over time. More than half of men in this category will never require surgery, radiation, or any aggressive treatment, which could otherwise be excessive given the indolent nature of their cancer.

How Is Prostate Cancer Quickly and Accurately Diagnosed at Arsbiomedica?
What diagnostic tools are available?

At Arsbiomedica, we utilize a state-of-the-art 3 Tesla MRI scanner, which allows for early and highly accurate detection of prostate cancer. When MRI findings, combined with PSA levels, raise suspicion of a tumor, we perform image-fusion guided prostate biopsies.

This advanced technique involves merging MRI images with real-time ultrasound, enabling us to guide a needle precisely to the suspicious area identified by the MRI. This allows us to extract targeted tissue samples with high precision.

The histological analysis of these tissue samples enables us to deliver an extremely accurate and early diagnosis, significantly improving the chances of successful treatment and personalized care.